SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-24-005715
Filing Date
2024-05-07
Accepted
2024-05-07 17:10:15
Documents
16
Period of Report
2024-05-07
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K drma_8k.htm   iXBRL 8-K 45813
2 THIRD AMENDMENT drma_ex101.htm EX-10.1 11186
  Complete submission text file 0001654954-24-005715.txt   205668

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA drma-20240507.xsd EX-101.SCH 6120
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE drma-20240507_lab.xml EX-101.LAB 16773
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE drma-20240507_cal.xml EX-101.CAL 898
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE drma-20240507_pre.xml EX-101.PRE 12288
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE drma-20240507_def.xml EX-101.DEF 4149
19 EXTRACTED XBRL INSTANCE DOCUMENT drma_8k_htm.xml XML 5732
Mailing Address 3525 DEL MAR HEIGHTS RD., #322 SAN DIEGO CA 92130
Business Address 3525 DEL MAR HEIGHTS RD., #322 SAN DIEGO CA 92130 (858)-223-0882
Dermata Therapeutics, Inc. (Filer) CIK: 0001853816 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40739 | Film No.: 24923132
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)